Earnings Feed
Start Free
Regulus Therapeutics Inc.·4

Jun 4, 5:00 PM ET

Klassen Preston 4

4 · Regulus Therapeutics Inc. · Filed Jun 4, 2025

Insider Transaction Report

Form 4
Period: 2025-06-03
Regulus Therapeutics Inc.RGLS
Klassen Preston
DirectorPresident & Head of R & D
Transactions
  • Purchase

    Common Stock

    2025-06-03$7.99/sh+12,000$95,852→ 48,055 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4